Alpine Associates Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-799,632
Closed -$142M 45
2020
Q1
$142M Sell
799,632
-220,468
-22% -$41.5M 5.63% 4
2019
Q4
$195M Buy
1,020,100
+33,600
+3% +$6.06M 6.21% 4
2019
Q3
$166M Buy
986,500
+354,900
+56% +$57.8M 5.44% 4
2019
Q2
$106M Buy
+631,600
New +$87.5M 3.11% 16
2016
Q3
Sell
-165,400
Closed -$38.2M 64
2016
Q2
$38.2M Sell
165,400
-377,900
-70% -$87.1M 1.36% 28
2016
Q1
$146M Buy
543,300
+361,700
+199% +$104M 5% 1
2015
Q4
$56.8M Buy
+181,600
New +$54.1M 1.86% 24
2015
Q3
Sell
-96,654
Closed -$29.3M 69
2015
Q2
$29.3M Buy
96,654
+20,400
+27% +$6.08M 0.95% 29
2015
Q1
$22.7M Buy
+76,254
New +$21.7M 0.82% 33

Other funds holding AGN

Alpine Associates Management's AGN Position: Q2 2020 in Review

Alpine Associates Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 799,632 shares — an estimated $142M sold.

Alpine Associates Management first reported a position in AGN in Q1 2015 and held it in 9 quarters. The position peaked at $195M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Alpine Associates Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Alpine Associates Management sold 799,632 Allergan plc shares in Q2 2020, an estimated $142M.
  • Alpine Associates Management first reported a position in Allergan plc in Q1 2015 and held it in 9 quarters.
  • Alpine Associates Management's Allergan plc position peaked at $195M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Alpine Associates Management's 13F filing for Q2 2020, filed 12 Aug 2020.